Globus Medical, Inc.

NYSE GMED

Globus Medical, Inc. Goodwill for the quarter ending September 30, 2024: USD 1.43 B

Globus Medical, Inc. Goodwill is USD 1.43 B for the quarter ending September 30, 2024, a 27.55% change year over year. Goodwill is the value attributed to intangible assets, such as brand reputation or customer relationships, acquired in a business combination.
  • Globus Medical, Inc. Goodwill for the quarter ending September 30, 2023 was USD 1.12 B, a 517.49% change year over year.
  • Globus Medical, Inc. Goodwill for the quarter ending September 30, 2022 was USD 181.77 M, a 9.12% change year over year.
  • Globus Medical, Inc. Goodwill for the quarter ending September 30, 2021 was USD 166.58 M, a 28.47% change year over year.
  • Globus Medical, Inc. Goodwill for the quarter ending September 30, 2020 was USD 129.66 M, a 0.51% change year over year.
Key data
Date Goodwill Total Assets Current Liabilities Total Non-Current Liabilities
Market news
Loading...
NYSE: GMED

Globus Medical, Inc.

CEO Mr. Daniel T. Scavilla
IPO Date Aug. 3, 2012
Location United States
Headquarters 2560 General Armistead Avenue
Employees 5,000
Sector Health Care
Industries
Description

Globus Medical, Inc., a medical device company, develops and commercializes healthcare solutions for patients with musculoskeletal disorders in the United States and internationally. It offers spine products, such as traditional fusion implants comprising pedicle screw and rod systems, plating systems, intervertebral spacers, and corpectomy devices for treating degenerative, deformity, tumors, and trauma conditions; treatment options for motion preservation technologies that consist of dynamic stabilization, total disc replacement, and interspinous distraction devices; interventional pain management solutions to treat vertebral compression fractures; and regenerative biologic products comprising of allografts and synthetic alternatives. The company also offers products for the treatment of orthopedic trauma, including fracture plates, compression screws, intramedullary nails, and external fixation systems; and hip and knee joint solutions, including modular hip stems and acetabular cups, as well as posterior stabilizing and cruciate retaining knee arthroplasty implants. In addition, it distributes human cell, tissue, and cellular and tissue-based products. Globus Medical, Inc. was incorporated in 2003 and is headquartered in Audubon, Pennsylvania.

Similar companies

PODD

Insulet Corporation

USD 267.04

-0.35%

BRKR

Bruker Corporation

USD 61.26

-2.69%

INSP

Inspire Medical Systems, Inc.

USD 169.99

-3.10%

CNMD

CONMED Corporation

USD 67.79

-2.46%

LIVN

LivaNova PLC

USD 47.63

0.66%

NVRO

Nevro Corp.

USD 3.70

-8.19%

ITGR

Integer Holdings Corporation

USD 138.83

2.72%

NARI

Inari Medical, Inc.

USD 79.30

-0.05%

ATEC

Alphatec Holdings, Inc.

USD 11.12

2.21%

NVCR

NovoCure Limited

USD 26.23

-4.20%

IRTC

iRhythm Technologies, Inc.

USD 99.01

4.67%

GKOS

Glaukos Corporation

USD 147.95

-2.58%

OFIX

Orthofix Medical Inc.

USD 17.51

0.81%

StockViz Staff

January 15, 2025

Any question? Send us an email